Activation of activator protein 1 and extracellular signal-regulated kinases in human hepatocellular transformation

被引:10
作者
Hsiang, CY
Wu, SL
Ho, TY
机构
[1] China Med Univ, Inst Chinese Med Sci, Taichung 404, Taiwan
[2] China Med Univ, Dept Microbiol, Taichung 404, Taiwan
[3] China Med Univ, Dept Biochem, Taichung 404, Taiwan
关键词
activator protein 1; mitogen-activated protein kinase; phorbol ester; hepatocytes;
D O I
10.1159/000081400
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma is one of the most common tumors worldwide. Activator protein 1 (AP-1) is a nuclear transcription factor, and its transactivation is required for transformation in several cell lines. However, no direct correlation between AP-1 activity and human hepatocellular transformation has been proved. Here we analyzed the role of AP-1 on the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced human hepatocellular transformation. TPA promoted the formation of anchorage-independent colonies, induced the AP-1 activity, and enhanced the DNA-binding ability of AP-1 in human hepatocytes. The phosphorylation of extracellular signal-regulated protein kinases ( ERKs) was increased by TPA and the TPA-induced AP-1 activity was inhibited by PD98059, indicating that TPA-induced AP-1 activation was via ERK pathway. Moreover, retinoic acid and PD98059, which inhibited the AP-1 activity, abolished the TPA-induced transformation. Our findings indicated that AP-1 and ERKs activations were required for TPA-induced human hepatocellular transformation. These studies suggested that AP-1 could be the target for the development of antihepatocellular transformation agents. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 30 条
[1]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[2]   PHORBOL ESTER INDUCIBLE GENES CONTAIN A COMMON CIS ELEMENT RECOGNIZED BY A TPA-MODULATED TRANS-ACTING FACTOR [J].
ANGEL, P ;
IMAGAWA, M ;
CHIU, R ;
STEIN, B ;
IMBRA, RJ ;
RAHMSDORF, HJ ;
JONAT, C ;
HERRLICH, P ;
KARIN, M .
CELL, 1987, 49 (06) :729-739
[3]  
[Anonymous], BIOCH BIOPHYS ACTA
[4]   Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy [J].
Barry, OP ;
Kazanietz, MG .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (17) :1725-1744
[5]   Molecular viral oncology of hepatocellular carcinoma [J].
Block, TM ;
Mehta, AS ;
Fimmel, CJ ;
Jordan, R .
ONCOGENE, 2003, 22 (33) :5093-5107
[6]  
Blum Hubert E, 2003, Hepatobiliary Pancreat Dis Int, V2, P11
[7]  
Blumberg P M, 1982, Carcinog Compr Surv, V7, P519
[8]   BLOCKING OF TUMOR PROMOTER-INDUCED AP-1 ACTIVITY INHIBITS INDUCED TRANSFORMATION IN JB6 MOUSE EPIDERMAL-CELLS [J].
DONG, ZG ;
BIRRER, MJ ;
WATTS, RG ;
MATRISIAN, LM ;
COLBURN, NH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :609-613
[9]  
Dragnev KH, 2003, CANCER BIOL THER, V2, pS150
[10]   A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE [J].
DUDLEY, DT ;
PANG, L ;
DECKER, SJ ;
BRIDGES, AJ ;
SALTIEL, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7686-7689